These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36416566)
1. Molecular dynamics and free energy calculations of clozapine bound to D2 and H1 receptors reveal a cardiometabolic mitigated derivative. Castañeda-Leautaud AC; Vidal-Limon A; Aguila SA J Biomol Struct Dyn; 2023 Nov; 41(19):9313-9325. PubMed ID: 36416566 [TBL] [Abstract][Full Text] [Related]
2. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801 [TBL] [Abstract][Full Text] [Related]
3. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Leysen JE; Janssen PM; Megens AA; Schotte A J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908 [TBL] [Abstract][Full Text] [Related]
4. Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. Roegge CS; Perraut C; Hao X; Levin ED Pharmacol Biochem Behav; 2007 Apr; 86(4):686-92. PubMed ID: 17382376 [TBL] [Abstract][Full Text] [Related]
5. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Aringhieri S; Carli M; Kolachalam S; Verdesca V; Cini E; Rossi M; McCormick PJ; Corsini GU; Maggio R; Scarselli M Pharmacol Ther; 2018 Dec; 192():20-41. PubMed ID: 29953902 [TBL] [Abstract][Full Text] [Related]
6. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist. Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699 [TBL] [Abstract][Full Text] [Related]
7. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427 [TBL] [Abstract][Full Text] [Related]
8. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor. Hjerde E; Dahl SG; Sylte I Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653 [TBL] [Abstract][Full Text] [Related]
9. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Seeman P; Tallerico T Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126 [TBL] [Abstract][Full Text] [Related]
10. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Schotte A; Janssen PF; Megens AA; Leysen JE Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574 [TBL] [Abstract][Full Text] [Related]
11. Modulation of leptin by histamine H1 receptors as a novel therapeutic approach for treatment of clozapine induced seizure. Ghanizadeh A Psychiatr Danub; 2010 Dec; 22(4):552-3. PubMed ID: 21169900 [No Abstract] [Full Text] [Related]
12. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Seeman P; Tallerico T Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836 [TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
14. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Kapur S; Zipursky RB; Remington G Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565 [TBL] [Abstract][Full Text] [Related]
15. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain? Deng C; Weston-Green K; Huang XF Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):1-4. PubMed ID: 19922755 [TBL] [Abstract][Full Text] [Related]
16. Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine. Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S Schizophr Res; 2008 Oct; 105(1-3):224-35. PubMed ID: 18710798 [TBL] [Abstract][Full Text] [Related]
17. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase. Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010 [TBL] [Abstract][Full Text] [Related]
18. Ligand Binding Pathways of Clozapine and Haloperidol in the Dopamine D2 and D3 Receptors. Thomas T; Fang Y; Yuriev E; Chalmers DK J Chem Inf Model; 2016 Feb; 56(2):308-21. PubMed ID: 26690887 [TBL] [Abstract][Full Text] [Related]
19. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Seeman P; Corbett R; Van Tol HH Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795 [TBL] [Abstract][Full Text] [Related]
20. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Farde L; Nordström AL; Wiesel FA; Pauli S; Halldin C; Sedvall G Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]